|
Q2 2021
Filed on Aug 16, 2021
|
807
|
$217.36 - $279.31
$175K - $225K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
5,154
|
$48.97 - $60.2
$252K - $310K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
10,099
|
$9.78 - $10.09
$98.8K - $102K
|
|
|
Q1 2021
Filed on May 10, 2021
|
2,004
|
$112.93 - $119.98
$226K - $240K
|
|
Nuveen Calif Municpal Value
|
Q1 2021
Filed on May 10, 2021
|
25,000
|
N/A
|
|
Allianzgi Conv & Income Fd I
|
Q1 2021
Filed on May 10, 2021
|
10,394
|
N/A
|
|
|
Q1 2021
Filed on May 10, 2021
|
10,000
|
N/A
|
|
Kins Technology Group Inc
|
Q1 2021
Filed on May 10, 2021
|
10,000
|
N/A
|
|
|
Q1 2021
Filed on May 10, 2021
|
10,000
|
N/A
|
|
|
Q1 2021
Filed on May 10, 2021
|
10,882
|
N/A
|
|
|
Q1 2021
Filed on May 10, 2021
|
19,282
|
$21.25 - $22.55
$410K - $435K
|
|
New Oriental Ed & Technology
|
Q1 2021
Filed on May 10, 2021
|
1,486
|
N/A
|
|
Golden Falcon Acquisition CO
|
Q1 2021
Filed on May 10, 2021
|
10,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 04, 2021
|
10,550
|
$16.51 - $23.59
$174K - $249K
|
|
|
Q4 2020
Filed on Feb 04, 2021
|
2,197
|
$117.06 - $118.42
$257K - $260K
|
|
|
Q4 2020
Filed on Feb 04, 2021
|
10,000
|
N/A
|
|
Perth Mint Physical Gold ETF
|
Q4 2020
Filed on Feb 04, 2021
|
10,500
|
N/A
|
|
|
Q4 2020
Filed on Feb 04, 2021
|
10,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 04, 2021
|
1,109
|
$177.97 - $207.98
$197K - $231K
|
|
|
Q4 2020
Filed on Feb 04, 2021
|
6,452
|
$35.71 - $53.01
$230K - $342K
|
|
Ascendant Digital Acquisitio
|
Q4 2020
Filed on Feb 04, 2021
|
10,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 04, 2021
|
5,460
|
$48.64 - $62.03
$266K - $339K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
21,280
|
$2.19 - $2.99
$46.6K - $63.6K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
4,394
|
$49.96 - $55.57
$220K - $244K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
24,313
|
$35.14 - $41.84
$854K - $1.02M
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
3,544
|
$74.79 - $85.06
$265K - $301K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
4,455
|
$38.06 - $50.2
$170K - $224K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
3,815
|
$126.86 - $150.7
$484K - $575K
|
|
|
Q3 2020
Filed on Oct 30, 2020
|
2,069
|
$94.08 - $104.7
$195K - $217K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
1,267
|
N/A
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
13,550
|
$29.67 - $80.0
$402K - $1.08M
|
|
Merrimack Pharmaceuticals In
|
Q2 2020
Filed on Aug 11, 2020
|
25,000
|
N/A
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
2,184
|
N/A
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
6,500
|
N/A
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
14,000
|
$14.43 - $19.16
$202K - $268K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
2,000
|
$37.49 - $61.24
$75K - $122K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
2,000
|
$90.0 - $111.18
$180K - $222K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
15,000
|
$1.9 - $5.61
$28.5K - $84.2K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
3,722
|
$53.38 - $65.93
$199K - $245K
|
|
Biomarin Pharmaceutical Inc
|
Q2 2020
Filed on Aug 11, 2020
|
200,000
|
N/A
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
1,372
|
$151.58 - $208.58
$208K - $286K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
20,456
|
N/A
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
10,050
|
$2.58 - $4.3
$25.9K - $43.2K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
2,370
|
$82.54 - $100.97
$196K - $239K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
22,540
|
$5.1 - $12.25
$115K - $276K
|
|
|
Q2 2020
Filed on Aug 11, 2020
|
3,981
|
$59.53 - $68.92
$237K - $274K
|
|
|
Q1 2020
Filed on Apr 13, 2020
|
3,000
|
N/A
|
|
|
Q1 2020
Filed on Apr 13, 2020
|
1,000
|
$84.57 - $110.24
$84.6K - $110K
|
|
|
Q1 2020
Filed on Apr 13, 2020
|
1,000
|
$16.65 - $24.31
$16.7K - $24.3K
|
|
|
Q1 2020
Filed on Apr 13, 2020
|
2,000
|
$56.91 - $99.57
$114K - $199K
|
|